The U.S. Food and Drug Administration has approved a kit that will allow women to collect their own vaginal sample for HPV screening, a move that could increase early detection in those at risk for cervical cancer. Women will be able to swab themselves in privacy at a doctor’s office, clinic or pharmacy, and the sample will then be sent off for analysis. More than half of U.S. women diagnosed with cervical cancer have never been screened or screened only infrequently for the virus, the kit’s maker Roche said in Read More
HEALTH DAILY NEWS
Health News, Medical News, Medical conditions, Medical Tests & Procedures, Symptoms, Medical Diagnosis , Health Information, FDA alerts, Drug Watch, Product Watch, Medicine Articles, Welfare, Living